Last Updated: November 8, 2026

Details for Patent: 10,342,850

« Back to Dashboard


Which drugs does patent 10,342,850 protect, and when does it expire?

Patent 10,342,850 protects BYNFEZIA PEN and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 10,342,850
Title:Octreotide injection
Abstract:The present invention relates to a sterile solution comprising: octreotide in the form of a pharmaceutically acceptable salt, present at a concentration equivalent to 2.0 mg/ml to 2.5 mg/ml of octreotide base, and at least one preservative in a pharmaceutically acceptable vehicle, wherein the sterile solution is present in an injection device.
Inventor(s):Amar RANA, Rakesh THUMMAR, Sudeep AGRAWAL, Subhas Balaram Bhowmick, Rajamannar Thennati
Assignee: Sun Pharmaceutical Industries Ltd
Application Number:US16/124,781
Patent Claim Types:
see list of patent claims
Formulation; Compound; Device;

Drugs Protected by US Patent 10,342,850

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sun Pharm BYNFEZIA PEN octreotide acetate SOLUTION;SUBCUTANEOUS 213224-001 Sep 27, 2024 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,342,850

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India201721017024May 15, 2017

International Family Members for US Patent 10,342,850

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 112019023981 ⤷  Start Trial
China 110678194 ⤷  Start Trial
European Patent Office 3624829 ⤷  Start Trial
Spain 3066409 ⤷  Start Trial
South Korea 20200003923 ⤷  Start Trial
Poland 3624829 ⤷  Start Trial
Russian Federation 2019136628 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.